Since Anti-CXCL5 mAb treatment has no significant effect on liver metabolism in ALI induced by APAP, we next examined whether treating Anti-CXCL5 mAb affects the hepatic inflammation process. This evidence concerns the gene CXCL5 and acute respiratory distress syndrome.